Yoshihiro Ito Selected Research

furfurylamine

1/2018

Collagen-Binding Hepatocyte Growth Factor (HGF) alone or with a Gelatin- furfurylamine Hydrogel Enhances Functional Recovery in Mice after Spinal Cord Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Ito Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 05/2009
8	Inflammation (Inflammations) 01/2021 - 10/2013
5	Obesity 01/2021 - 02/2012
4	Hyperglycemia 01/2022 - 11/2017
4	Insulin Resistance 01/2021 - 02/2012
3	Dermatitis 11/2022 - 01/2021
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 11/2008
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021 - 07/2012
3	Hypersensitivity (Allergy) 10/2014 - 12/2011
3	Leukemia 05/2009 - 05/2004
2	Stroke (Strokes) 03/2022 - 10/2015
2	Thyroiditis 12/2021 - 03/2018
2	Hypoxia (Hypoxemia) 11/2021 - 11/2021
2	Bulimia (Binge Eating) 01/2021 - 10/2019
2	Body Weight (Weight, Body) 01/2021 - 04/2016
2	Diabetes Insipidus 10/2020 - 01/2018
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 03/2020 - 01/2018
2	Polyuria 03/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2019 - 01/2018
2	Heart Failure 11/2019 - 06/2011
2	Multiple Myeloma 10/2019 - 08/2007
2	Wounds and Injuries (Trauma) 01/2018 - 02/2011
2	Disease Progression 07/2017 - 05/2014
2	Neoplasm Metastasis (Metastasis) 01/2013 - 03/2011
2	Aplastic Anemia (Anemia, Hypoplastic) 02/2012 - 10/2002
2	Paraproteinemias (Monoclonal Gammopathy) 01/2010 - 08/2007
2	Bone Resorption 08/2008 - 02/2007
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2008 - 03/2003
2	Infections 07/2005 - 12/2002
2	Cleft Palate (Palate, Cleft) 02/2005 - 11/2003
2	Refractory Anemia 01/2004 - 10/2002
1	Liposarcoma 02/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Multiple System Atrophy 01/2022
1	Gliosis 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Down Syndrome Critical Region 05/2021

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2017
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 05/2021 - 08/2007
5	Arginine Vasopressin (Argipressin)IBA 11/2020 - 01/2018
4	LeptinIBA 01/2022 - 02/2012
4	Streptozocin (Streptozotocin)FDA Link 01/2022 - 11/2017
4	AntibodiesIBA 12/2021 - 09/2012
4	Insulin (Novolin)FDA Link 12/2021 - 11/2017
4	Messenger RNA (mRNA)IBA 07/2021 - 01/2017
3	Biological ProductsIBA 02/2022 - 01/2004
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 10/2013
3	B7-H1 AntigenIBA 01/2021 - 10/2020
3	Monoclonal AntibodiesIBA 01/2021 - 09/2012
3	Immune Checkpoint InhibitorsIBA 10/2020 - 03/2018
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2019 - 08/2007
3	CollagenIBA 01/2018 - 08/2007
3	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2016 - 09/2011
3	Immunoglobulins (Immunoglobulin)IBA 01/2010 - 08/2007
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2022 - 11/2017
2	Nerve Growth Factor (NGF)IBA 01/2022 - 01/2019
2	Hormones (Hormone)IBA 01/2022 - 03/2011
2	PolymersIBA 11/2021 - 11/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021 - 11/2021
2	pullulanIBA 11/2021 - 11/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021 - 02/2012
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021 - 10/2020
2	GlucocorticoidsIBA 01/2021 - 10/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 02/2017
2	CytokinesIBA 01/2020 - 05/2004
2	Folic Acid (Vitamin M)FDA LinkGeneric 04/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 10/2011
2	GelatinIBA 12/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2007
2	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2016 - 09/2011
2	Peptides (Polypeptides)IBA 10/2015 - 05/2009
2	Keratin-14 (Keratin 14)IBA 04/2014 - 02/2005
2	EnzymesIBA 11/2013 - 02/2009
2	AutoantibodiesIBA 11/2013 - 11/2008
2	AntigensIBA 01/2013 - 12/2011
2	Immunoglobulin M (IgM)IBA 01/2010 - 07/2005
2	Erythropoietin FDA Link 05/2004 - 10/2002
1	LipidsIBA 11/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Dihydroxyphenylalanine (Dopa)IBA 01/2022
1	THK5351IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2021
1	Sodium-Glucose Transport ProteinsIBA 12/2021
1	Thyroglobulin FDA Link 12/2021
1	PolyethyleneimineIBA 11/2021
1	Cytidine Monophosphate (CMP)IBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 08/2021

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2002
7	Drug Therapy (Chemotherapy) 10/2020 - 08/2007
2	Immunotherapy 01/2021 - 05/2020
2	Aftercare (After-Treatment) 03/2011 - 03/2003
1	Length of Stay 03/2022
1	Activities of Daily Living (ADL) 03/2022
1	Transplantation 01/2022